Trial Profile
A Phase I Study of BBI608 Administered With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Napabucasin (Primary) ; Bevacizumab; Irinotecan; Levofolinic acid
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sumitomo Dainippon Pharma
- 21 Mar 2017 Status changed from recruiting to completed.
- 08 Jan 2016 New trial record